Starpharma Pty Ltd (External organisation)

Description

Modified Macromolecules
JP5989294B2 - Japan
The present invention relates to macromolecules, particularly dendrimers that can control their surface architecture so that the proportion of certain topological isomers is concentrated, their production, and their use. In particular, the polymer has two or more surface groups, and at least one of the surface groups can be pharmaceutically active.

Period	7 Sept 2016
Held at	Starpharma Pty Ltd, Australia, Victoria